Allergy reduces the risk of meningioma: a meta-analysis

Peng-Fei Wang1, Wen-Jun Ji2, Xiao-Hui Zhang3

  • 1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, China.

Scientific Reports
|January 11, 2017
PubMed

Insights

Allergic conditions, including asthma and eczema, are associated with a reduced risk of developing meningiomas, the most common brain tumors. This meta-analysis suggests allergies may offer a protective effect against meningioma development.

Area of Science:

  • Neuro-oncology
  • Epidemiology
  • Immunology

Background:

  • Meningiomas are the most common primary brain tumors, but their etiology remains poorly understood.
  • Existing data on the link between atopic (allergic) diseases and meningioma risk are inconsistent.

Purpose of the Study:

  • To conduct a meta-analysis investigating the association between allergic conditions and the risk of developing meningioma.
  • To clarify the relationship between specific allergic diseases and meningioma risk.

Main Methods:

  • A systematic literature search was performed using PubMed and Web of Science databases (1979-2016).
  • Included studies were evaluated by two independent investigators based on predefined criteria.
  • Data from 8 case-control and 2 cohort studies, involving 5,679 meningioma cases and 55,621 controls, were pooled for analysis.

Main Results:

  • A pooled odds ratio (OR) of 0.81 (95% CI: 0.70-0.94) indicated a reduced risk of meningioma in individuals with allergic conditions compared to those without.
  • Inverse correlations were observed for asthma (OR: 0.78; 0.70-0.86) and eczema (OR: 0.78; 0.69-0.87).
  • Hay fever showed a weaker, though significant, association with reduced meningioma risk (OR: 0.88; 0.78-0.99).

Conclusions:

  • The findings suggest that allergic conditions are associated with a decreased risk of developing meningiomas.
  • Potential confounding variables may contribute to heterogeneity across studies.
  • Further large-scale cohort studies are warranted to confirm this protective association.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Allergic Reactions02:06

Allergic Reactions

Overview
33.1K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
94
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
568
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80